<rdf:RDF
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
    xmlns:j.0="http://www.ddmore.org/ontologies/webannotationtool#"
    xmlns:j.1="http://www.pharmml.org/ontology/"
    xmlns:j.2="http://www.pharmml.org/2013/10/PharmMLMetadata#" > 
  <rdf:Description rdf:about="http://repository.ddmore.eu/model/DDMODEL00000229">
    <j.2:model-tasks-in-scope rdf:resource="http://www.ddmore.org/ontologies/ontology/pkpd-ontology#pkpd_0006001"/>
    <rdf:type rdf:resource="http://www.pharmml.org/ontology/PHARMMLO_0000001"/>
    <j.2:model-field-purpose rdf:resource="http://www.ddmore.org/ontologies/ontology/pkpd-ontology#pkpd_0000036"/>
    <j.0:model-implementation-conforms-to-literature-controlled rdf:datatype="http://www.w3.org/2001/XMLSchema#string">No</j.0:model-implementation-conforms-to-literature-controlled>
    <j.2:model-modelling-question rdf:resource="http://www.ddmore.org/ontologies/ontology/pkpd-ontology#pkpd_0006034"/>
    <j.2:model-has-description rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The model is a mechanism-based model for oncotherapy by a conjugated mAb drug, Gemtuzumab ozogamicin (GO; commercial name Mylotarg), for patients with acute myeloid leukemia (AML). The model illustrates the interactions of the drug, GO, with leukemic blasts expressing a receptor, the cell surface antigen CD33, to which the mAb component of the drug (i.e. Gemtuzumab) binds. The drug-antigen complex is then internalized, allowing for the toxic component (ozogamicin) to induce cell lysis. The system consists of ordinary differential equations describing the dynamics of the drug, receptor, and drug-receptor complex, as well as the drug pharmacokinetics. </j.2:model-has-description>
    <j.2:model-modelling-question rdf:resource="http://www.ddmore.org/ontologies/ontology/pkpd-ontology#pkpd_0006026"/>
    <j.2:model-tasks-in-scope rdf:resource="http://www.ddmore.org/ontologies/ontology/pkpd-ontology#pkpd_0006000"/>
    <j.2:model-research-stage rdf:resource="http://www.ddmore.org/ontologies/ontology/pkpd-ontology#pkpd_0006009"/>
    <j.0:model-implementation-source-discrepancies-freetext rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The PK model was extended to include one peripheral compartment. The main reason is that the model was re-evaluated on the same data, using mixed-effects approach in Monolix.</j.0:model-implementation-source-discrepancies-freetext>
    <j.2:model-research-stage rdf:resource="http://www.ddmore.org/ontologies/ontology/pkpd-ontology#pkpd_0006004"/>
    <j.0:model-origin-of-code-in-literature-controlled rdf:datatype="http://www.w3.org/2001/XMLSchema#string">No</j.0:model-origin-of-code-in-literature-controlled>
  </rdf:Description>
</rdf:RDF>
